- Home
- WLGS vs CALC Comparison
WLGS vs CALC Comparison
Compare WLGS & CALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WLGS
- CALC
- Stock Information
- Founded
- WLGS 1981
- CALC 2011
- Country
- WLGS Hong Kong
- CALC United States
- Employees
- WLGS N/A
- CALC N/A
- Industry
- WLGS Engineering & Construction
- CALC Biotechnology: Pharmaceutical Preparations
- Sector
- WLGS Consumer Discretionary
- CALC Health Care
- Exchange
- WLGS Nasdaq
- CALC Nasdaq
- Market Cap
- WLGS 41.7M
- CALC 40.3M
- IPO Year
- WLGS 2023
- CALC N/A
- Fundamental
- Price
- WLGS $5.14
- CALC $3.09
- Analyst Decision
- WLGS
- CALC Strong Buy
- Analyst Count
- WLGS 0
- CALC 5
- Target Price
- WLGS N/A
- CALC $18.20
- AVG Volume (30 Days)
- WLGS 269.9K
- CALC 26.8K
- Earning Date
- WLGS 02-21-2025
- CALC 11-13-2024
- Dividend Yield
- WLGS N/A
- CALC N/A
- EPS Growth
- WLGS N/A
- CALC N/A
- EPS
- WLGS 0.02
- CALC N/A
- Revenue
- WLGS $7,272,879.00
- CALC N/A
- Revenue This Year
- WLGS N/A
- CALC N/A
- Revenue Next Year
- WLGS N/A
- CALC N/A
- P/E Ratio
- WLGS $292.33
- CALC N/A
- Revenue Growth
- WLGS 66.93
- CALC N/A
- 52 Week Low
- WLGS $0.44
- CALC $2.05
- 52 Week High
- WLGS $5.57
- CALC $8.38
- Technical
- Relative Strength Index (RSI)
- WLGS 75.69
- CALC 50.07
- Support Level
- WLGS $1.39
- CALC $2.73
- Resistance Level
- WLGS $2.41
- CALC $3.28
- Average True Range (ATR)
- WLGS 0.54
- CALC 0.29
- MACD
- WLGS 0.38
- CALC 0.02
- Stochastic Oscillator
- WLGS 99.73
- CALC 42.00
About WLGS Wang & Lee Group Inc.
WANG & LEE Group Inc operates as an investment holding company. The firm conducts its primary operations through its indirectly wholly owned subsidiary WANG and LEE CONTRACTING LIMITED (WLHK). WLHK provides contract engineering, installation, and out-fitting of the following products and services: low voltage (220v/phase 1 or 380v/phase 3) electrical systems, mechanical ventilation and air-conditioning systems (MVAC), fire safety systems, and water supply and sewage disposal systems.
About CALC CalciMedica Inc.
CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapies for life-threatening inflammatory diseases with high unmet need. Its proprietary technology targets the inhibition of calcium release-activated calcium channels designed to modulate the immune response and protect against tissue cell injury, with the potential to provide therapeutic benefits in life-threatening inflammatory diseases for which there are no approved therapies.